Skip to main content
. Author manuscript; available in PMC: 2008 May 30.
Published in final edited form as: J Lipid Res. 2005 Aug 1;46(10):2122–2133. doi: 10.1194/jlr.M500230-JLR200

Fig. 2.

Fig. 2

Inhibition of [3H]mevalonic acid labeling of cPLA2γ with the protein farnesyltransferase inhibitor BMS-214662. IMLF−/− were infected with Ad-cPLA2γ and incubated with or without 1 μM BMS-214662. cPLA2γ was immunoprecipitated, separated by SDS-PAGE, and subjected to fluorography.